CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 25,341	$ 28,397
Accounts receivable	1,256	731
Grants receivable	9,480	9,172
Inventories	18,821	13,503
Prepaid expenses and other current assets	6,753	14,203
Total current assets	61,651	66,006
Property and equipment, net	56,305	58,515
Operating lease right-of-use assets	1,725	2,016
Intangible assets, net	14,547	15,680
Other assets	4,741	4,084
Total assets	138,969	146,301
Current liabilities:
Accounts payable, including due to related party of $303 and $147, respectively	22,135	10,066
Accrued expenses and other current liabilities, including due to related party of $2,791 and $5,664 respectively	9,715	13,660
Deferred income	33,702	32,370
Operating lease liabilities	550	541
Convertible promissory notes due to related party, held at fair value		27,128
Notes payable	3,177	1,950
Warrant liabilities		15,821
Total current liabilities	69,279	101,536
Deferred income	9,040	8,914
Operating lease liabilities	1,222	1,519
Notes payable, including due to related party of $15,223 and $16,523, respectively	30,015	35,131
Warrant liabilities	1,130
Earnout liability	6,190
Other long-term liabilities, including due to related party of $3,062 and $2,416, respectively	5,908	5,588
Total liabilities	122,784	152,688
Commitments and contingencies (Note 19)
Noncontrolling interest	11,087	11,855
Stockholders' equity (deficit):
Preferred stock, $0.0001 par value - 250,000,000 shares authorized at June 30, 2022; zero shares issued and outstanding at June 30, 2022 and December 31, 2021
Common stock, $0.0001 par value - 900,000,000 shares authorized at June 30, 2022; 72,552,477 shares issued and outstanding at June 30, 2022; 125,961,571 shares authorized at December 31, 2021; 6,248,192 shares issued and outstanding at December 31, 2021	7	1
Additional paid-in capital	289,332	(64,549)
Accumulated other comprehensive (loss) income	(344)	219
Accumulated deficit	(283,896)	(265,507)
Total stockholders' equity (deficit)	5,098	(329,836)
Total liabilities, noncontrolling interest, redeemable convertible preferred stock and stockholders' equity (deficit)	$ 138,969	146,301
Legacy Gelesis Redeemable Convertible Preferred Stock
Current liabilities:
Legacy Gelesis redeemable convertible preferred stock, $0.0001 par value - zero shares issued and outstanding at June 30, 2022; 51,730,762 shares authorized at December 31, 2021; and 48,566,655 shares issued and outstanding at December 31, 2021		$ 311,594